Actelion Forks Over $250M For Pa. Drugmaker
Actelion US Holdings Co., a subsidiary of Swiss biotechnology giant Actelion Ltd., will acquire Pennsylvania drugmaker Ceptaris Therapeutics Inc. for a total of $250 million, it was announced Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article